Collectively, our current study identified that the overexpression of menin facilitated the malignant behaviors of BLCA cells by boosting β-catenin via activating TFAP2C, suggesting that menin might serve as a therapeutic target and prognostic marker for BLCA (Fig. 7). This evidence concerns the gene MEN1 and bladder transitional cell carcinoma.